HM Payson & Co. lowered its position in MetLife, Inc. (NYSE:MET) by 11.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,051 shares of the financial services provider’s stock after selling 658 shares during the period. HM Payson & Co.’s holdings in MetLife were worth $267,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of MET. Foothills Asset Management Ltd. acquired a new stake in shares of MetLife during the first quarter worth about $2,237,000. First National Bank of Omaha acquired a new stake in shares of MetLife during the first quarter worth about $206,000. Bank of Montreal Can increased its stake in shares of MetLife by 14.9% in the first quarter. Bank of Montreal Can now owns 1,510,026 shares of the financial services provider’s stock worth $79,760,000 after buying an additional 196,115 shares during the last quarter. E&G Advisors LP increased its stake in shares of MetLife by 9.9% in the first quarter. E&G Advisors LP now owns 5,571 shares of the financial services provider’s stock worth $294,000 after buying an additional 500 shares during the last quarter. Finally, Carroll Financial Associates Inc. increased its stake in shares of MetLife by 15.0% in the first quarter. Carroll Financial Associates Inc. now owns 2,847 shares of the financial services provider’s stock worth $150,000 after buying an additional 372 shares during the last quarter. 74.83% of the stock is owned by hedge funds and other institutional investors.

MetLife, Inc. (NYSE MET) traded up 0.56% during midday trading on Monday, reaching $48.32. The company had a trading volume of 2,260,682 shares. MetLife, Inc. has a 12 month low of $38.87 and a 12 month high of $58.09. The firm’s 50-day moving average price is $54.59 and its 200 day moving average price is $53.07. The firm has a market capitalization of $52.54 billion, a PE ratio of 542.92 and a beta of 1.46.

MetLife (NYSE:MET) last released its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The company had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. During the same quarter last year, the business posted $0.83 EPS. MetLife’s quarterly revenue was up 2.5% compared to the same quarter last year. Equities analysts anticipate that MetLife, Inc. will post $5.31 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Monday, August 7th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.97%. The ex-dividend date of this dividend is Thursday, August 3rd. MetLife’s dividend payout ratio (DPR) is 1,777.98%.

COPYRIGHT VIOLATION WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/08/07/metlife-inc-met-stake-decreased-by-hm-payson-co.html.

A number of analysts recently issued reports on the company. Citigroup Inc. set a $51.00 price objective on MetLife and gave the stock a “sell” rating in a research report on Friday, July 7th. Wells Fargo & Company reissued an “outperform” rating and set a $63.00 price objective (up from $61.00) on shares of MetLife in a research report on Wednesday, July 12th. Royal Bank Of Canada reissued a “buy” rating and set a $62.00 price objective on shares of MetLife in a research report on Wednesday, July 12th. Keefe, Bruyette & Woods reissued a “buy” rating and set a $59.00 price objective on shares of MetLife in a research report on Thursday. Finally, TheStreet raised MetLife from a “c” rating to a “b-” rating in a research report on Monday, July 24th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $59.02.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.